Tempest Therapeutics, Inc. [TPST]

Source: 

Company Overview

Tempest Therapeutics, Inc. is a clinical-stage biotechnology company moving into late-stage development with a diverse portfolio of novel targeted and immune-mediated product candidates with the potential to be first-in-class treatments for a wide range of cancers.